VIMAL SHAHAdd: 99 HARRINGTON ROAD, DOOR NO F1, 15TH AVENUE CHETPET,

CHENNAI -60003 1, Email: norrisexport:rmgmail.com

11/11/2019

To,NORRIS M EDICINES LIMITED

PLOT NO. 801/P, GIDC,ANKLESHWAR BHARUCH 393002

Sub: Intimation/Disclosures under SEBI (Substantial Acquisition of Shares andTakeovers) Regulations, 2011

Dear Sir,

Pursuant to th e provrsions of Regulation 29(1) of SEBI (Substant ial Acquisition ofShares and Takeovers) Regulat ions, 2011 and the amendments made therein, I wish toinform you th at, I, VIMAL SHAH have acquired 23,60,441 Equity Shares (23.60%) ofRs. 10/- each of M/s. NORRIS MEDICINES LIMITED in Off Market Inter SeTransacti on .

Please find enclosed herewith th e relevant informat ion in the prescribed Format.

I request you to kindly take th e above informati on on you r record .

Thanking you,

VI M AL SHAHPlace: CHENNAI

Encl: As above

VIMAL SHAHAdd: 99 HARRINGTON ROAD, DOOR NO F1, 15TH AVENUE CHETPET,

CH ENNAI - 6000 31 , Email: norrisexport1ii>gmail.com

11/11/2019

To,

BSE LimitedDepartment of Corporate ServicesP. J. Tower, Dalal Street,Mumbai 400 001

Sub: Intimation/Disclosures under SEBI (Substantial Acquisition of Shares andTakeovers) Regulations, 2011.

Dear Sir,

Pursuant to the provisrons of Regulation 29(1) of SEBI (Substantial Acquisition ofShares and Takeovers) Regulations, 2011 and the amendments made therein, I wish toinform you that, I, VIMAL SHAH have acquired 23,60,441 Equity Shares (23.60%) ofRs. 101- each of Mis. NORRIS MEDICINES LIMITED in Off Market Inter SeTransaction.

Please find enclosed herewith the relevant information in the prescribed Format.

I request you to kindly take the above information on your record.

Thanking you ,

Yours sincerely

VIMAL SHAHPlace: CHENNAI

End: As above

FORMAT FOR DISCLOSURES UNDER REGULATION 29(1) OF SEBI (SUBSTANTIALACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS, 2011

Part -A- Detai ls of the Acquisition

Name of the Target Company (TC)

Name(s) of the acquirer and PersonsActing in Concert (PAC) with the acquirerWhether the acquirer belongs toPromoter/Promoter qroupName(s) of the Stock Exchange(s) wher e theshares of TC are Listed

NORRIS MEDICINES LIMITED

VIMALSHAH

YES

BSE Limited

Details of the acquisition as follows

Before the acquisition underconsideration, holding of acquireralong with PACs of:

Number % w.r.t. total

share/voti ng

capital

whe reverapplicable(*)

% w.r.t total

diluted

share/voting

capita l ofthe rc (**)

a) Shares carrying voting rights

b) Shares in the nature of encum brance(pledge/ lien/ non -disposalund ertaking/ others)

c) Voting rig hts (VR) otherwise than byequi ty shares

d) Warrants/ convert ib le securitie s/ anyother instrument that ent it les theacquirer to receive shares carryingvot ing rights in the TC (specifyholding in each category)

e) Tot al (a+b+c+d)

Details of acquisition

34,350

Nil

Nil

Nil

34,350

0.34%

N.A.

N.A.

N.A.

0.34%

0.34%

N.A.

N.A.

N.A.

0.34%

a) Shares carrying voting righ ts acquired 23,60,441 23.60% 23.60%

b) VRs acquired otherwise th an byequ ity shares

c) Warrants/convertible securities/anyoth er inst rument tha t entitles theacqui rer to receive shares carryin gvot ing rights in the TC (specifyholding in each category) acquired

d) Shares in the nature of encumbrance(pledge/ lien/ non -d isposalundertak ing/ others)

e) Total (a+b+c+/-d)

After the acquisition, holding ofacquirer along with PACs of:

a) Shares carrying voting rights

b) VRs otherwise than by equity shares

c) Warrants/convertible securities/anyother instrument that entitles theacquirer to receive shares carryingvot ing righ ts in the TC (specifyholding in each category) afteracquisition

d) Shares in the nature of encumbrance(pledge/ lien/ non-disposalund ertaking/ others)

e) Total (a+b+c+d)

Nil

Nil

Nil

23,60,441

23,94,791

Nil

Nil

Nil

23,94,791

N.A.

N.A.

N.A.

23.60%

23.95%

N.A.

N.A.

N.A.

23.95%

N.A.

N.A.

N.A.

23.60%

23.95%

N.A.

N.A.

N.A.

23.95%

Mode of acquisition (e.g. open market /public issue / rig hts issue / preferentialallotment / inter-se transfer/encumbrance,etc.)

Salient features of the securities acquired

OFF MARKET - INTER SE TRANSFER

Not Applicable

including time t ill redem ption, rati o at whichit can be converted into equity shares, etc.

Date of acquisition of! date of receipt of 8 /11/ 2019intimati on of allotment of shares / VR/warrants/convertible securit ies/ any otherinstrument that enti tl es the acquirer toreceive shares in the TC.

Equity share capital/ total vot ing capita l of 1,00,00,700 Equity Shares of Rs. 10/- eachthe TC before the said acquisit ionEquity share capital/ total voti ng capital of 1,00,00,700 Equity Shares of Rs. 10/- eachthe TC after t he said acquisit ionTotal di luted share/ vot ing capital of the TC 1,00,00,700 Equity Shares of Rs. 10/- eachafter the said acquisiti on

Part-B***

Name of the Target Company: NORRIS MEDICINES LIMITED

Name(s) of the Acquirer Whether the acquirer PAN of the Acquirer and/or

and Person Acting in belongs to PACs

Concert (PAC) with the Promoter/Promoter Group

Acquirer

VIMAL SHAH YES ACJPV6228J

-r:VIMAL SHAH

PROMOTER & ACQUIRER

PLACE: CHENNAIDate: 11/11/2019

Note:

(*) Total share capita l/ vot ing capital to be taken as per the latest fi ling do ne by the com panyto the Stock Exchange unde r Clause 35 of th e list ing Agreement.

(**) Diluted share/vot ing capita l means ;the to tal number of shares in the TC assuming fujiconversion of the outstanding convertible securiti es/warrants into equity shares of the TC.

(***) Part- B shall be disclosed to the Stock Exchanges but shall not be disseminate d.